In October 2019 researchers from Brazil identified a new parasite, which presented with similar symptoms to visceral leishmaniasis. To discover more about this novel parasite and other parasitic diseases in Brazil, we interviewed Sandra Maruyama from the Federal University of São Carlos (UFSCar; São Paulo, Brazil) about her research and the future of this field.
Researchers have discovered an association between the spread of HIV and quantity of extracellular vesicles from lactobacilli, suggesting a protective mechanism to inhibit the spread of HIV infection.
Published in Nature, new research elucidates the mechanism behind malarial resistance to piperaquine and suggests how this knowledge could be used to combat its spread.
Researchers have discovered that a relatively ancient drug efflux pump from Haemophilus influenzae exports the same antibiotics as its evolved counterpart from Escherichia coli, but was mitigated by a leaky porin channel.
Researchers have uncovered the mechanism used by predatory bacteria, Bdellovibrio bacteriovorus, to initiate prey invasion.
Researchers have investigated a toxin–antitoxin system in tuberculosis as a therapeutic target, providing the first high-resolution details.
New research has suggested that vaccinia viruses trick infected host cells into activating their cell movement mechanism, rapidly spreading the virus.
Gauri Godbole, from Public Health England, gives us an overview of recent advances and updates in the field of gastrointestinal infections – from the impact of the microbiome to the growing threat of antimicrobial resistance.
Researchers from the Center for Infection and Immunity have made a major breakthrough in diagnoses of pathogenic bacteria with their design, the BacCapSeq platform. It’s the first precision medicine platform to allow simultaneous screening for all known bacterial pathogens, as well as markers for antibiotic resistance and virulence.
A team from the Okinawa Institute of Science and Technology Graduate University has used cryo-EM to model the nucleocapsid protein of Ebola virus, potentially uncovering novel drug targets.
